My research interests revolve around immunotherapy of NSCLC patients; how can we improve treatment outcome for this patient group. I try to understand why immunotherapy (combinatorial strategies) are effective in some NSCLC patients and not at all in others, and use this knowledge to stratify patients or improve treatment design.  In order to achieve this, I make use of multi-color flowcytometry, ELISA, cell-culture, cytokine assays and histology to evaluate blood, tumor-draining lymph nodes and tumor from NSCLC patients.

Immunotherapy ,

Immunotherapy, Lymph Node, NSCLC, Biomarkers, Intratumoral